Publication: Clinical Evaluation of Safety and Efficacy of a 670-nm Picosecond Laser for Treatment of Benign Pigmented Lesions in Asians
Issued Date
2021-05-01
Resource Type
ISSN
15244725
10760512
10760512
Other identifier(s)
2-s2.0-85105106667
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Dermatologic Surgery. Vol.47, No.5 (2021), E153-E158
Suggested Citation
Kristy E.R. Evangelista, Woraphong Manuskiatti, Rungsima Wanitphakdeedecha, Thanya Techapichetvanich Clinical Evaluation of Safety and Efficacy of a 670-nm Picosecond Laser for Treatment of Benign Pigmented Lesions in Asians. Dermatologic Surgery. Vol.47, No.5 (2021), E153-E158. doi:10.1097/DSS.0000000000002880 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/78244
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Clinical Evaluation of Safety and Efficacy of a 670-nm Picosecond Laser for Treatment of Benign Pigmented Lesions in Asians
Other Contributor(s)
Abstract
BACKGROUNDPicosecond lasers are increasingly being investigated in treating pigmentation disorders because they may provide better treatment efficacy and comfort compared with nanosecond lasers.OBJECTIVEThis study aims to evaluate the efficacy and side effect of a novel 670-nm picosecond laser in the removal of benign pigmented lesions (BPLs) in individuals with Fitzpatrick skin types (FST) III and IV.MATERIALS AND METHODSFifteen subjects with solar lentigines and 7 subjects with ABNOMs received a single treatment with a 670-nm picosecond laser. Blinded physicians assessed the pigment clearance using a 5-category grading system scale. All subjects were evaluated at 1 month, 3 month, and 6 month after a single treatment. Adverse events were recorded at every follow-up visit.RESULTSAll subjects with lentigines had complete clearance (95%-100%) of lesions during 3-month follow-up after a single treatment session of 670-nm picosecond laser, whereas 75% of the subjects with ABNOMs noted fair lightning (25%-49%) of lesions. Mild hypopigmentation and hyperpigmentation were observed in 9% and 14% of the subjects, respectively, which resolved within 3 months after the treatment.CONCLUSIONThe novel 670-nm picosecond laser is a safe and effective treatment for BPLs in subjects with FST III and IV with low rates of transient adverse effects.